Abstract
The objective of this study was to assess the role of 18F- fluorodeoxyglucose positron emission tomography (FDG-PET) for the characterization of ovarian masses that were diagnosed as ovarian malignancies by magnetic resonance imaging (MRI). We performed a retrospective review of eight patients with pathologically confirmed borderline ovarian tumors (BOT) who underwent MRI and FDG-PET before surgical staging from August 2005 to March 2007. We assessed the PET imaging of the BOT, measured the FDG uptake and quantified the findings as a standardized uptake value (SUV). The FDG-PET scans, of all eight patients, showed uptake of FDG with a mean SUV of less than 2.0 in the solid portion of the masses evaluated. We conclude that the MRI-PET differences may help differentiate borderline from malignant ovarian tumors.
Original language | English |
---|---|
Pages (from-to) | 637-641 |
Number of pages | 5 |
Journal | International Journal of Gynecological Cancer |
Volume | 18 |
Issue number | 4 |
DOIs | |
State | Published - Jul 2008 |
Keywords
- Borderline ovarian tumor
- MRI
- PET